智通财经APP获悉，春立医疗(01858)早盘涨超11%，截至发稿，涨7.17%，报9.27港元，成交额2118.53万港元。
消息面上，春立医疗发布2025年第一季度报告，该集团取得营业收入2.3亿元，同比增加3.6%；归属于上市公司股东的净利润5807.11万元，同比增加5.2%；基本每股收益0.15元。
华泰证券发布研报称，在国内部分业务仍受到集采影响的环境下，春立医疗一季度整体业绩保持稳健增长主因海外业务表现出色。25年国内各业务有望改善：关节方面，集采续标顺利，髋关节渠道退换货影响基本消化，膝关节集采顺利续标有望带来业绩增量；运动医学方面，公司借助集采报量机会进入空白医院，推动销售快速放量；脊柱方面，集采后有望受益量增。国内集采影响消化叠加海外业绩持续拓展，看好25年业绩增速恢复。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.